Publicacións (20) Publicacións nas que participase algún/ha investigador/a

2008

  1. ADAMTS-13 activity and von Willebrand factor levels in methylene blue photo-inactivated plasma processed by either the Springe method or an 'in house' system

    Vox Sanguinis, Vol. 95, Núm. 2, pp. 101-105

  2. Apoptosis in fresh and cryopreserved cardiac valves of pig samples

    Cell and Tissue Banking, Vol. 9, Núm. 2, pp. 101-107

  3. Body mass index and mortality in patients with acute venous thromboembolism: Findings from the RIETE registry

    Journal of Thrombosis and Haemostasis, Vol. 6, Núm. 4, pp. 595-600

  4. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin

    Blood, Vol. 111, Núm. 7, pp. 3395-3402

  5. Coexistencia de Síndrome Lifoproliferativo Crónico y Síndrome Mieloproliferativo Crónico en tres pacientes

    Anales de Medicina Interna, Vol. 25, Núm. 2, pp. 78-80

  6. Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain

    Blood Coagulation and Fibrinolysis, Vol. 19, Núm. 5, pp. 333-340

  7. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

    Journal of Thrombosis and Haemostasis, Vol. 6, Núm. 5, pp. 762-771

  8. Diagnostic value of JC/BK virus antibody immunohistochemistry staining in urine samples from posttransplant immunosuppressed patients in relation to polyomavirus reactivation

    Acta Cytologica, Vol. 52, Núm. 2, pp. 191-195

  9. Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the european study: Molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)

    Blood, Vol. 111, Núm. 10, pp. 4979-4985

  10. Linfomas orbitarios: Presentación de nueve casos

    Archivos de la Sociedad Española de Oftalmologia, Vol. 83, Núm. 2, pp. 95-104

  11. Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: A multicentric, prospective cohort study

    British Journal of Haematology, Vol. 143, Núm. 1, pp. 39-45

  12. Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study

    Medicina Clinica, Vol. 131, Núm. 11, pp. 401-405

  13. Primary mediastinal large cell lymphoma (PMBL): Frontline treatment with autologous stem celltransplantation (ASCT). The GEL-TAMO experience

    Hematological Oncology, Vol. 26, Núm. 3, pp. 171-178

  14. Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain

    Medicina Clinica, Vol. 131, Núm. 12, pp. 441-446

  15. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: The influence of prior exposure to rituximab on outcome. A GEL/TAMO study

    Haematologica, Vol. 93, Núm. 12, pp. 1829-1836

  16. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): Results from the European Study MCMDM-1VWD

    Blood, Vol. 111, Núm. 7, pp. 3531-3539

  17. Tratamiento de rescate de la infección fúngica invasora. Concepto y recomendaciones actuales

    Medicina Clinica Monografias, Vol. 9, Núm. 9, pp. 31-36

  18. Técnica de cultivo de mioblastos autólogos humanos para transplante clínico

    Trauma, Vol. 19, Núm. 1, pp. 62-67

  19. Update on pulmonary infections in patients with hematologic malignancies and hematopoietic stem cell recipients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 3, pp. 58-71

  20. Valoración diagnóstica y pronóstica de los síndromes mielodisplásticos

    Hematología práctica, Vol. 3, Núm. 2, pp. 21-28